Skip to content

China STEMI Care Project

China STEMI Care Project: a 10-year Project to Improve Quality of Care by Building up the a Regional STEMI Care Network

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03821012
Enrollment
50000
Registered
2019-01-29
Start date
2011-01-31
Completion date
2021-12-31
Last updated
2019-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ST-Elevation Myocardial Infarction

Brief summary

The China ST-elevation myocardial infarction (STEMI) Care Project (CSCAP) aims to improve the reperfusion treatment rate and shorten the total duration of myocardial ischemia by establishing a regional STEMI treatment network covering the whole-city region, whole-city population, and whole-disease process step by step. The CSCAP is a prospective, multicenter registry involving three phases. A total of 18 provinces, 4 municipalities, and 2 autonomous regions in China were included. Patients with STEMI who met with the third acute myocardial infarction definition and the Chinese STEMI diagnosis and treatment guidelines were enrolled and the estimated number is over 50,000. Phase 1 (CSCAP-1) focused on the in-hospital process optimization of primary percutaneous coronary intervention (PPCI) hospitals. Phase 2 (CSCAP-2) focused on the PPCI hospital-based regional STEMI transfer network, including emergency medical services and non-PPCI hospitals. Phase 3 (CSCAP-3) focused on the whole-city STEMI care network construction by promoting chest pain center accreditation. Systematic data collection, assessment of quality of care, and subsequent improvement were implemented throughout the project to continuously improve the quality of care for patients with STEMI. CSCAP is the first project that focused on establishing a regional STEMI emergency care network in China to help understand the condition of STEMI care in China extensively. Moreover, its objective was to optimize the quality of STEMI care through in-hospital process optimization (2012-2013), PPCI hospital-based regional STEMI transfer network construction (2015-2018), and construction of the whole-city STEMI care network step by step (2018-2021). However, hospitals were not randomly selected in CSCAP, which might be because of the lack of representatives to some degree. Alternatively, it focused on providing a tailored quality-of-care improvement plan based on the conditions of different regions.

Interventions

OTHERin-hospital process optimization
OTHERPPCI hospital-based regional STEMI transfer network construction
OTHERthe whole-city STEMI care network construction

Sponsors

Peking University First Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* STEMI patients

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
the total duration of myocardial ischemia12 hoursMedian time from symptom onset to target vessel open in STEMI patients
the reperfusion treatment ratio12 hoursthe ratio of primary PCI plus thrombolysis usage in STEMI patients

Countries

China

Contacts

Primary ContactYan Zhang, MD
drzhy1108@163.com8610-83575728

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026